“The work that I am doing may one day assist in providing new ways of identifying and monitoring cancer. This means that physicians could find cancer earlier and provide patients with better treatment options, tailored to their individual disease at that moment in time. This would improve patient’s prognosis and quality of life, which is the most important thing in the world.”
Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking for 7-8 highly motivated scientists and engineers to participate in the coming 6-month co-op period. Participants will be matched with one of 35 leading Boston researchers and clinicians for a mentored, hands-on research experience in cancer nanomedicine. Participants will learn about how nanotechnology can be used for the prevention, detection, and treatment of cancer by networking with world experts, attending specialized workshops and seminars, and presenting at scientific conferences. Don’t miss this chance to get involved in the world’s first undergraduate program in cancer nanomedicine!
All applications should be submitted through NUcareers. The Spring application deadline is February 25, 2018.
The CaNCURE Experience
Trainees will perform full-time research for six months in the laboratory of a CaNCURE mentor. Specialized workshops, seminars, and continuing education activities round out each trainee’s research experience. Key components of the CaNCURE program include:
- Mentoring by a world leader in cancer nanomedicine
- Hypothesis-driven research within an NCI-funded laboratory
- Problem-solving as part of team with graduate students and post-docs
- Team-building through participation in lab meetings, CaNCURE orientation, & workshops
- Networking with invited guest speakers
- Presentation of research findings at local and national conferences
Northeastern University who have completed at least one co-op (or equivalent research experience) are eligible for the CaNCURE program. Participants will be selected based on the following criteria:
- Interest in cancer research, with a focus on cancer nanomedicine
- Academic and outreach achievements
- Recommendation from co-op mentor or STEM course instructor
Participants will be matched with a CaNCURE mentor for a hands-on research co-op experience, for which they will receive a $6000 stipend. The stipend will be paid over the middle 4 months of co-op (Aug-Nov or Feb-May). Applicants must U.S. citizens or permanent residents. Women and underrepresented minorities are encouraged to apply.
CaNCURE participants will complete one co-op, during which they are expected to work for 40 hours/wk for 6 months. This co-op is available twice yearly, from January to June and July to December. Additionally, all participants are required to attend the NU National Nanomedicine Seminar Series during their co-op. Trainees will be provided with an orientation at the start of their co-op to become familiar with important concepts in cancer nanomedicine. During their co-op, students will maintain an e-Portfolio to track their accomplishments. After completion of their co-op, participants will present their research at the annual CaNCURE day in order to showcase the program and its activities to the wider community, as well as prepare video entry for NU’s Coolest Co-op Competition. Opportunities for continuing education and professional development will be provided throughout the co-op. Funding is also available for participants to attend local and national conferences in order to present the results of their research.
We are now accepting applications for Fall 2018. Interested students should consult submitted through NUcareers to view the full job description and download the application. Applications are due February 25, 2018.
Opportunities for Continued Training
Following the completion of their co-op, students are encouraged to continue attending our year-round scientific and bio/nano innovation seminar series. Students can also attend one or more Nanomedicine courses including NNMD 5270, 5370, 5470, 5272, and 5474. Every student who has expressed an interest in continuing to work in their CaNCURE lab has been able to do so, and many of these students were paid or received course credit for their research activities. The CaNCURE staff is available to help with organizing these and other cancer research opportunities.
Where our Alumni are Now
|Medical & Graduate Schools||Industry||Research & Clinical Care|
|Stanford Medical School||EMD Serono||Dana-Farber Cancer Institute|
|UPenn Medical School||Jounce Therapeutics||Belfer Center for Applied Cancer Sciences|
|SUNY Upstate College of Medicine||Crisper Therapeutics||MGH Center for Cancer Research|
|UConn School of Medicine||Britax Oncology||Broad Institute|
|Quinnipiac University||Takeda Oncology||Mass. Department of Public Health|
|University of London||inviCRO, LLC||Undiagnosed Diseases Network|
UNE Medical School
|Boston Consulting Group||Brigham and Women’s Hospital|
|UAB School of Medicine|
UVM School of Medicine
|UMass Medical School|
Why You Should Join
CaNCURE has trained over 50 undergraduates since 2015. These students have joined us from 11 different majors, including behavioral neuroscience, biology, biochemistry, bioengineering, biomedical physics, cell and molecular biology, chemical engineering, English, health sciences, nursing, and physics. Our large pool of mentors ensures that we can pair each student with a mentor who matches their background, research interests, and career goals.
CaNCURE trainees have published 13 papers, presented 12 talks and 63 posters at conferences, and won 20 awards to-date.
47% of our alumni have continued to work in their CaNCURE lab after the co-op, with the goal of writing a paper, performing research for credit, or writing a senior thesis.
52% of our alumni are currently performing cancer research as part of a new co-op (students) or full-time job (graduates).
100% of our alumni who applied for post-graduate education got into medical school or graduate school on their first try.